This issue describes the Russian commercial pharmacy market in May 2007.
Drugs commercial market value increased by 17.6% (in dollars) in the period of January-May 2007 compared to that of 2006 and amounted to $2193 mln.
The drugs commercial market value (in pharmacy purchase prices) decreased by 2.6% in May compared to April 2007 and amounted to $441 mln (VAT included); however it is 18.4% higher than in May 2006.
The weighted average price per drug unit on the Russian commercial market amounted to 38.17 rubles ($1.48) which is 5.45% lower (in ruble terms) than in April 2007.
Prices on the commercial pharmacy market increased in May compared to April 2007 by 0.4% in dollars and by 0.3% in rubles.
Drugs consumption structure did not changed in May 2007 compared to April 2007. The average unit price increased at three price segments: by 10.28% at “Under 50 rubles” segment, at 2.55% for “50–150 rubles” segment, by 0.91% at “150–500” segment. However the figure decreased by 6.42% for the expensive drugs priced at more than 500 rubles per unit.
In May 2007, domestic and imported drugs ratio in value terms amounted to 23% and 77% correspondingly. In unit terms domestic drugs share slightly decreased: from 70% in May 2006 to 66% in May 2007.
The proportion of Rx and OTC drugs on the pharmaceutical market is stable. In May 2007 Rx drugs cover 61% of commercial sales value. In unit terms Rx drugs share amounted to 38% in May 2007.
In May 2007 Sanofi-Aventis leads TOP-10 drugs manufactures. Berlin-Chemie /A.Menarini/ increased its share by 0.2% and is the 2nd in May 2007, while Pharmstandard is the 3rd one.
Pharmstandard shows maximum growth in share (+47.3%) for the period of May 2006 — May 2007.
The 1st one among the TOP-20 leading drug trade names of May 2007 is Actovegin. Viagra rose from the 3rd position to the 2nd one. Enap with its share of 0.75% became the 3rd.
For the period of January-May 2007 Russian NS (nutritional supplements) pharmacy market value increased by 6% compared to that of 2006 and amounted to $140 mln.
NS market value decreased from $30 mln in April to $27 mln in May 2007 (-10.7%). However it increased in May 2007 by 2.3% in value terms in comparison to the previous month.
The weighted average cost per NS unit is $1.62 (42 rubles) in May 2007 which is 14% lower than in April.
Capilar (by Diod) still leads the TOP-20 NS trade names. Bilberry-Forte and Ovesol (both by Evalar) are the 2nd and the 3rd ones. AlphaVIT (by Akva-MDT/Akvion) left TOP-3 in April 2007 due to 33.6% share decrease. It is 4th in May 2007.
TOP-3 NS manufacturers on the NS commercial market stayed the same in May 2007.
All market reviews by DSM Group are available on the page Analytics.
